Albany, NY -- (SBWIRE) -- 12/18/2017 -- Cancers and their treatments have been a challenge in the past and continue to be so due to increase in prevalence of new types of cancer. For medical science, cancer is one of the major platforms for research and development. It has also benefited medical and pharmaceutical companies to generate revenue. There has been extensive developments in terms of technology and drugs used to treat cancer. One of the techniques used in the treatment of cancer is to increase body temperature externally to treat the tumor. The technique is being accepted globally at a significant pace. Hyperthermia cancer treatment involves exposing the body to high temperature of around 42 degree Celsius. Hyperthermia is often used with other cancer treatments such as radiation therapy and chemotherapy. Several methods of hyperthermia are under ongoing research study, including local, regional, and whole-body hyperthermia. Various clinical trials are underway to evaluate the effectiveness of hyperthermia. Hyperthermia kills or weakens the disorganized tumour cells that are having compact vascular structure and have difficulty in dissipating heat. In this procedure cancerous cells undergo apoptosis as a response of applying heat on the affected portion.

Report Overview and TOC @ https://www.transparencymarketresearch.com/hyperthermia-cancer-treatment-market.html

The cancer therapy market is driven by increase in the number of cases per annum and the number of cancer patients across the globe. Cancer has a significant impact on the population of the U.S. and the world. The statistics provide information on the number of people diagnosed and mortality rate of cancer each year and other parameters such as average age at cancer diagnosis and patients who are still alive at a given time after diagnosis. These factors help in collecting data for further use in research and development of techniques to cure cancer. According to the National Cancer Institute, in 2016, around 1,685,200 new cases of cancer were diagnosed in the U.S. and 595,700 people died from the disease. This in turn is expected to fuel the growth of the hyperthermia cancer treatment market in the near future.

Lesser side effects is a major factor expected to boost the growth of the hyperthermia cancer treatment market during the forecast period. The technique is based on the application of high temperature and does not have adverse effects as compared to other cancer treatments such as radiation therapy and chemotherapy. This is expected to increase the adoption rate of hyperthermia cancer treatment.

Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31334

The global hyperthermia cancer treatment market can be segmented based on device type, type of cancer, location, hyperthermia type, end-user, and region. In terms of device type, the market can be categorized into microwave hyperthermia device, ultrasound hyperthermia device, short-wave hyperthermia device, and infrared hyperthermia device. The microwave hyperthermia device segment is anticipated to dominate the global market in the near future, followed by the ultrasound hyperthermia device segment due to lesser side effects.

Based on type of cancer, the global hyperthermia cancer treatment market can be classified into lung, breast, soft tissue, leukemia, head and neck tumors, and others. According to World Health Organization's research study, cancer is a leading cause of death globally. The study estimated 8.8 million deaths in 2015 due to cancer; lung cancer accounted for 1.69 million deaths and breast cancer was responsible for 0.57 million deaths. In terms of location, the global hyperthermia cancer treatment market can be divided into local hyperthermia, regional hyperthermia, and whole-body hyperthermia. Based on hyperthermia type, the market can be segmented into high intensity focused ultrasound, induction heating, and magnetic hyperthermia.

Geographically, the global hyperthermia cancer treatment market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the global market during the forecast period. This is attributed to the presence of leading market players and health care organizations in the region. Meanwhile, untapped region in the developing markets are lucrative markets for hyperthermia cancer treatment market. Large population, expanding health care facilities and health care expenditure, and rising incidence of cancer in countries such as India and China are expected to augment the hyperthermia cancer treatment market in the region.

Pre Book full report@ https://www.transparencymarketresearch.com

Major players operating in the global hyperthermia cancer treatment market are Celsius42+ GmbH, Pyrexar Medical, Inc., Oncotherm Ltd. LLC, Hydrosun GmbH, Endomagnetics Limited, Andromedic Srl, Nanobacterie, BSD Medical Corporation, Nanoprobes, Inc., and Nanotherics.